PDS completes merger with Edge Therapeutics
PRINCETON: PDS Biotechnology Corporation, a clinical-stage immuno-oncology company pioneering the development of novel multifunctional immunotherapeutic products,has announced the closing of its merger with Edge Therapeutics, Inc. Following the merger, Edge…